Luis Chávez-Sánchez1, Montserrat Guadalupe Garza-Reyes2, José Esteban Espinosa-Luna1, Karina Chávez-Rueda1, María Victoria Legorreta-Haquet1, Francisco Blanco-Favela3. 1. Unidad de Investigación Médica en Inmunología, UMAE, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, IMSS, México D.F., Mexico. 2. Unidad de Investigación Médica en Inmunología, UMAE, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, IMSS, México D.F., Mexico; Departamento de Inmunología, ENCB, IPN, México D.F., Mexico. 3. Unidad de Investigación Médica en Inmunología, UMAE, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, IMSS, México D.F., Mexico. Electronic address: fblanco1@terra.com.mx.
Abstract
UNLABELLED: Toll-like receptor (TLR)2, TLR4 and CD36 are central in inflammation and the development of atherosclerosis. Oxidized low-density lipoprotein (oxLDL) plays a critical role in this disease through its involvement in the formation of foam cells and the activation of leukocytes. The aim of this research was to analyze the role of TLR2, TLR4 and CD36 in foam cell differentiation and macrophage activation. METHODS: Human macrophages were incubated with monoclonal antibodies specific for TLR2, TLR4 and CD36 prior to stimulation with oxLDL. Subsequently, we analyzed foam cell formation, cytokine secretion, histocompatibility complex (MHC) class II molecules and CD86 expression and T cell proliferation. RESULTS: The stimulation of macrophages with oxLDL induced foam cell formation, cytokine secretion, HLA-DR and CD86 expression and T cell proliferation. The blockage of TLR2, TLR4 and CD36 reduced the secretion of IL-1β, IL-6 and IL-8, the expression of HLA-DR and CD86, T cell proliferation and foam cell formation. However, the blockage of TLR2 did not affect the formation of foam cells. CONCLUSION: Our study demonstrates that TLR2, TLR4 and CD36 participate in the immune response to oxLDL by inducing an increase in pro-inflammatory cytokines, the expression HLA-DR and CD86 and the proliferation of T cells. However, TLR2 does not participate in the formation of foam cells, while TLR4 and CD36 play a relevant role in this process. These findings suggest that the activation of these receptors by oxLDL contributes to the pathogenesis of atherosclerosis.
UNLABELLED: Toll-like receptor (TLR)2, TLR4 and CD36 are central in inflammation and the development of atherosclerosis. Oxidized low-density lipoprotein (oxLDL) plays a critical role in this disease through its involvement in the formation of foam cells and the activation of leukocytes. The aim of this research was to analyze the role of TLR2, TLR4 and CD36 in foam cell differentiation and macrophage activation. METHODS:Human macrophages were incubated with monoclonal antibodies specific for TLR2, TLR4 and CD36 prior to stimulation with oxLDL. Subsequently, we analyzed foam cell formation, cytokine secretion, histocompatibility complex (MHC) class II molecules and CD86 expression and T cell proliferation. RESULTS: The stimulation of macrophages with oxLDL induced foam cell formation, cytokine secretion, HLA-DR and CD86 expression and T cell proliferation. The blockage of TLR2, TLR4 and CD36 reduced the secretion of IL-1β, IL-6 and IL-8, the expression of HLA-DR and CD86, T cell proliferation and foam cell formation. However, the blockage of TLR2 did not affect the formation of foam cells. CONCLUSION: Our study demonstrates that TLR2, TLR4 and CD36 participate in the immune response to oxLDL by inducing an increase in pro-inflammatory cytokines, the expression HLA-DR and CD86 and the proliferation of T cells. However, TLR2 does not participate in the formation of foam cells, while TLR4 and CD36 play a relevant role in this process. These findings suggest that the activation of these receptors by oxLDL contributes to the pathogenesis of atherosclerosis.
Authors: Charan V Devarakonda; Flavia E Pereira; Jonathan D Smith; Linda H Shapiro; Mallika Ghosh Journal: Atherosclerosis Date: 2019-06-13 Impact factor: 5.162
Authors: Scott W Walsh; Anuja A Chumble; Sonya L Washington; Kellie J Archer; Sinem E Sahingur; Jerome F Strauss Journal: J Reprod Immunol Date: 2017-06-03 Impact factor: 4.054
Authors: Qingchun Zeng; Rui Song; David A Fullerton; Lihua Ao; Yufeng Zhai; Suzhao Li; Dov B Ballak; Joseph C Cleveland; T Brett Reece; Timothy A McKinsey; Dingli Xu; Charles A Dinarello; Xianzhong Meng Journal: Proc Natl Acad Sci U S A Date: 2017-01-30 Impact factor: 11.205
Authors: Jerry J Flores; Damon Klebe; William B Rolland; Tim Lekic; Paul R Krafft; John H Zhang Journal: Neurobiol Dis Date: 2015-12-29 Impact factor: 5.996
Authors: Benjamin J Moyer; Itzel Y Rojas; Joanna S Kerley-Hamilton; Haley F Hazlett; Krishnamurthy V Nemani; Heidi W Trask; Rachel J West; Leslie E Lupien; Alan J Collins; Carol S Ringelberg; Barjor Gimi; William B Kinlaw; Craig R Tomlinson Journal: Toxicol Appl Pharmacol Date: 2016-03-25 Impact factor: 4.219